Skip to main content

Table 3 Outcome and intensive care treatment of patients without frailty (CFS < 5) and disability (ADL 6), patients with either disability (ADL < 6) or frailty (CFS ≥ 5), or both frailty and disability

From: The association of the Activities of Daily Living and the outcome of old intensive care patients suffering from COVID-19

 

Non-frailty (CFS < 5)/no disability (ADL 6)

Frailty (CFS ≥ 5) or disability (ADL < 6)

Frailty and disability

p-value

Invasive mechanical ventilation

76% (1388)

62% (162)

68% (183)

 < 0.001

Non-invasive mechanical ventilation

23% (414)

29% (75)

31% (84)

0.002

Tracheostomy

21% (376)

12% (31)

10% (28)

 < 0.001

Vasoactive drugs

72% (1312)

58% (149)

67% (178)

 < 0.001

RRT

14% (255)

16% (41)

23% (61)

 < 0.001

Life sustaining care withheld

30% (540)

42% (106)

31% (83)

 < 0.001

Life sustaining care withdrawn

20% (369)

21% (52)

16% (44)

0.32

ICU mortality

45% (810)

55% (140)

67% (180)

 < 0.001

30-day mortality

46% (848)

63% (162)

72% (195)

 < 0.001

3-month mortality

52% (945)

68% (176)

78% (210)

 < 0.001

  1. ADL Activities of Daily Living, CFS Clinical Frailty Scale, RRT renal replacement therapy, p-value comparing all groups. [Numbers do not add up to 100% due to missing values]